FindTrial
Sign In

Comparative effectiveness of low-dose versus standard-dose tissue plasminogen activator for acute ischemic stroke patients

Comparative effectiveness of low-dose versus standard-dose tissue plasminogen activator for acute ischemic stroke patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001048
Enrollment
1600
Registered
2014-04-11
Start date
2013-12-18
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Admitted between November 2009 and March 2013 / 2) Neuroimage-documented ischemic stroke / 3) within 4.5 hours from last seen normal time / 4) tPA-treated cases

Exclusion criteria

Exclusion criteria: 1) No information on tPA dose / 2) No information on mRS score at 3 month / 3) No information on symptomatic hemorrhagic transformation

Design outcomes

Primary

MeasureTime frame
mRS score at 3 months after stroke onset;symptomatic hemorrhagic transformation—

Secondary

MeasureTime frame
mRS score at discharge—

Countries

Korea, Republic of

Contacts

Public ContactSEUNG LEE

Seoul National University Bundang Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026